{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:48:00Z","timestamp":1782348480559,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","award":["MOE 107QR001I5"],"award-info":[{"award-number":["MOE 107QR001I5"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107-2119-M-007-016"],"award-info":[{"award-number":["107-2119-M-007-016"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.addr.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:21:23Z","timestamp":1544055683000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems"],"prefix":"10.1016","volume":"139","author":[{"given":"Yu-Jung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fwu-Long","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Bao","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tringyo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Wen","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2018.12.001_bb0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.12.001_bb0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.addr.2016.02.011","article-title":"Oral delivery of diabetes peptides- comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context","volume":"106","author":"Lakkireddy","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.addr.2017.01.006","article-title":"Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery","volume":"112","author":"Pechenov","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(01)05842-1","article-title":"Insulins today and beyond","volume":"358","author":"Owens","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2018.12.001_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2018.12.001_bb0030","doi-asserted-by":"crossref","first-page":"21075","DOI":"10.1073\/pnas.1118922109","article-title":"Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs","volume":"108","author":"Frost","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2018.12.001_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0169-409X(98)00072-6","article-title":"Current status and future prospects of parenteral insulin regimens, strategies and delivery systems for diabetes treatment","volume":"35","author":"Jeandidier","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0040","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2018.12.001_bb0045","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrd.2015.36","article-title":"Pursuit of a perfect insulin","volume":"15","author":"Zaykov","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.12.001_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2003.08.011","article-title":"Closed-loop insulin delivery-the path to physiological glucose control","volume":"56","author":"Steil","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0055","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.addr.2007.08.019","article-title":"Current challenges in non-invasive insulin delivery systems: a comparative review","volume":"59","author":"Khafagy","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0060","doi-asserted-by":"crossref","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","article-title":"A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery","volume":"32","author":"Chen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0065","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.ddtec.2011.11.006","article-title":"Overcoming poor permeability: translating permeation enhancers for oral peptide delivery","volume":"9","author":"Maher","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2018.12.001_bb0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.addr.2012.10.010","article-title":"Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules","volume":"65","author":"Chen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0075","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/mi.2010.5","article-title":"Multiple facets of intestinal permeability and epithelial handling of dietary antigens","volume":"3","author":"M\u00e9nard","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2018.12.001_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0169-409X(91)90013-3","article-title":"Mechanisms of peptide and protein absorption: paracellular intestinal transport: modulation of absorption","volume":"7","author":"Nellans","year":"1991","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2006.01.003","article-title":"Tight junction modulation and its relationship to drug delivery","volume":"58","author":"Salama","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0090","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0169-409X(01)00231-9","article-title":"Oral drug absorption enhancement by chitosan and its derivatives","volume":"52","author":"Thanou","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0095","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.biomaterials.2011.12.038","article-title":"Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery","volume":"33","author":"Su","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2012.11.011","article-title":"Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery","volume":"169","author":"Chuang","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0105","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gut.29.8.1035","article-title":"Measurement of gastrointestinal pH profiles in normal ambulant human subjects","volume":"29","author":"Evans","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.addr.2018.12.001_bb0110","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","article-title":"In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery","volume":"30","author":"Sonaje","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0115","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.biomaterials.2011.10.075","article-title":"Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport","volume":"33","author":"Jin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/mabi.201300384","article-title":"Biodegradable, pH-responsive carboxymethyl cellulose\/poly(acrylic acid) hydrogels for oral insulin delivery","volume":"14","author":"Gao","year":"2014","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2018.12.001_bb0125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2018.12.001_bb0130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0168-3659(01)00408-4","article-title":"Trypsin inhibition, calcium and zinc ion binding of starch-g-poly(acrylic acid) copolymers and starch\/poly(acrylic acid) mixtures for peroral peptide drug delivery","volume":"75","author":"Ameye","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0135","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1023\/A:1016024322209","article-title":"Evidence for the existence of insulin-degrading enzyme on the brush-border membranes of rat enterocytes","volume":"13","author":"Chang","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.12.001_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2018.12.001_bb0145","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2015.06.035","article-title":"Self-assembling bubble carriers for oral protein delivery","volume":"64","author":"Chuang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0150","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0155","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1016\/j.biomaterials.2012.05.013","article-title":"Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan","volume":"33","author":"Hsu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0160","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.biomaterials.2012.09.082","article-title":"Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions","volume":"34","author":"Hsu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0165","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2008.07.004","article-title":"Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel","volume":"132","author":"Kim","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0170","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/bm049312a","article-title":"Preparation of nanoparticles composed of chitosan\/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells","volume":"6","author":"Lin","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2018.12.001_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0939-6411(03)00145-0","article-title":"Development of acrylic-based copolymers for oral insulin delivery","volume":"57","author":"Foss","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2018.12.001_bb0180","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.polymer.2013.01.050","article-title":"Biodegradable pH-responsive polyacrylic acid derivative hydrogels with tunable swelling behavior for oral delivery of insulin","volume":"54","author":"Gao","year":"2013","journal-title":"Polymer"},{"key":"10.1016\/j.addr.2018.12.001_bb0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2003.12.022","article-title":"Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics","volume":"95","author":"Nakamura","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0190","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2005.10.029","article-title":"Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats","volume":"110","author":"Morishita","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0195","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/j.biomaterials.2009.06.055","article-title":"Drug permeability and mucoadhesion properties of thiolatedtrimethyl chitosan nanoparticles in oral insulin delivery","volume":"30","author":"Yin","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0200","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2009.01.011","article-title":"Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption","volume":"135","author":"Rekha","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2007.08.051","article-title":"Beneficial properties for insulin absorption using superporous hydrogel containing interpenetrating polymer network as oral delivery vehicles","volume":"350","author":"Yin","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2018.12.001_bb0210","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.carbpol.2014.06.045","article-title":"pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery","volume":"112","author":"Mukhopadhyay","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2018.12.001_bb0215","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1021\/bm900035u","article-title":"Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles","volume":"10","author":"Cui","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2018.12.001_bb0220","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1021\/bm401580k","article-title":"Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration","volume":"15","author":"Agrawal","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2018.12.001_bb0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/bm0607776","article-title":"Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery","volume":"8","author":"Lin","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2018.12.001_bb0230","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1016\/j.biomaterials.2010.01.042","article-title":"Enteric-coated capsules filled with freeze-dried chitosan\/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0235","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1016\/j.biomaterials.2010.05.042","article-title":"Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection","volume":"31","author":"Sonaje","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0240","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.12.001_bb0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2010.09.016","article-title":"Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin","volume":"77","author":"Zhang","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2018.12.001_bb0250","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijbiomac.2014.08.040","article-title":"pH-sensitive chitosan\/alginate core-shell nanoparticles for efficient and safe oral insulin delivery","volume":"72","author":"Mukhopadhyay","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2018.12.001_bb0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.12.025","article-title":"Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats","volume":"293","author":"Ma","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2018.12.001_bb0260","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.biomaterials.2017.03.028","article-title":"Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin","volume":"130","author":"He","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0265","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1463-1326.2011.01546.x","article-title":"Preparation, characterization and in vivo evaluation of pH\u2013sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles","volume":"14","author":"Yang","year":"2012","journal-title":"Diabetes. Obes. Metab."},{"key":"10.1016\/j.addr.2018.12.001_bb0270","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2147\/IJN.S81715","article-title":"pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin","volume":"10","author":"Sun","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2018.12.001_bb0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/ijms18010054","article-title":"Multifunctional composite microcapsules for oral delivery of insulin","volume":"18","author":"Sun","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2018.12.001_bb0280","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1080\/10717544.2016.1212440","article-title":"Polymeric lipid vesicles with pH-responsive turning on-off membrane for programed delivery of insulin in GI tract","volume":"23","author":"Fang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2018.12.001_bb0285","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11095-005-9444-5","article-title":"Magnetically responsive polymeric microparticles for oral delivery of protein drugs","volume":"23","author":"Cheng","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2018.12.001_bb0290","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.biomaterials.2007.11.018","article-title":"The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules","volume":"29","author":"Teply","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0295","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1039\/c3cs60436e","article-title":"Emerging micro- and nanotechnology based synthetic approaches for insulin delivery","volume":"43","author":"Mo","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.msec.2016.06.059","article-title":"A composite hydrogel system containing glucose-responsive nanocarriers for oral delivery of insulin","volume":"69","author":"Li","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.addr.2018.12.001_bb0305","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd836","article-title":"New horizons--alternative routes for insulin therapy","volume":"1","author":"Owens","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.addr.2018.12.001_bb0310","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","article-title":"A review of intranasal formulations for the treatment of seizure emergencies","volume":"237","author":"Kapoor","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0315","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","article-title":"Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives","volume":"57","author":"Ugwoke","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0320","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1517\/17425247.2011.607437","article-title":"Nasal route: an alternative approach for antiemetic drug delivery","volume":"11","author":"Ozsoy","year":"2011","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2018.12.001_bb0325","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.drudis.2010.03.011","article-title":"New strategies to improve the intranasal absorption of insulin","volume":"15","author":"Duan","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2018.12.001_bb0330","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10717544.2014.920431","article-title":"Nasal-nanotechnology: revolution for efficient therapeutics delivery","volume":"23","author":"Kumar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2018.12.001_bb0335","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.carbpol.2010.04.068","article-title":"Effects of interpenetration of thermo-sensitive gels by crosslinking of chitosan on nasal delivery of insulin: in vitro characterization and in vivo study","volume":"82","author":"Chung","year":"2010","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2018.12.001_bb0340","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.biomaterials.2006.12.024","article-title":"A thermosensitive hydrogel based on quaternized chitosan and poly (ethylene glycol) for nasal drug delivery system","volume":"28","author":"Wu","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0345","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1039\/C2BM00132B","article-title":"A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation","volume":"1","author":"Nazar","year":"2013","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2018.12.001_bb0350","doi-asserted-by":"crossref","first-page":"E184","DOI":"10.1208\/pt060227","article-title":"Nasal insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies","volume":"6","author":"D'Souza","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2018.12.001_bb0355","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/17425247.2013.746659","article-title":"Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery","volume":"10","author":"Singh","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2018.12.001_bb0360","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.drudis.2015.10.016","article-title":"Smart materials: in situ gel-forming systems for nasal delivery","volume":"21","author":"Karavasili","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2018.12.001_bb0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcis.2004.12.033","article-title":"Poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide)-g-poly (vinylpyrrolidone): association behavior in aqueous solution and interaction with anionic surfactants","volume":"285","author":"Zhang","year":"2005","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.addr.2018.12.001_bb0370","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/17425247.4.3.297","article-title":"Design of fine particles for pulmonary drug delivery","volume":"4","author":"Weers","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2018.12.001_bb0380","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jconrel.2012.05.040","article-title":"Recent advances in nanocarrier-based mucosal delivery of biomolecules","volume":"161","author":"Kammona","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.02.014","article-title":"Prospects of formulating proteins\/peptides as aerosols for pulmonary drug delivery","volume":"314","author":"Shoyele","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2018.12.001_bb0390","first-page":"1","article-title":"Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases","volume":"3","author":"Smola","year":"2008","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2018.12.001_bb0395","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.nano.2015.01.007","article-title":"Inhalable nanoparticulate powders for respiratory delivery","volume":"11","author":"Muralidharan","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2018.12.001_bb0400","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.2042-7158.2012.01486.x","article-title":"Engineered PLGA nano- and micro- carriers for pulmonary delivery: challenges and promises","volume":"64","author":"Ungaro","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2018.12.001_bb0405","first-page":"501","article-title":"Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats","volume":"2","author":"Karathanasis","year":"2007","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2018.12.001_bb0410","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.nano.2015.05.006","article-title":"Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin","volume":"11","author":"Andrade","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2018.12.001_bb0415","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2006.04.004","article-title":"Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats","volume":"113","author":"Karathanasis","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2018.12.001_bb0420","first-page":"L183","article-title":"Glucose transport and equilibrium across alveolar-airway barrier of rat","volume":"270","author":"Saumon","year":"1996","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.addr.2018.12.001_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0169-409X(95)00113-L","article-title":"Mechanisms of macromolecule absorption by the lungs","volume":"19","author":"Patton","year":"1996","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2018.12.001_bb0430","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/nn400630x","article-title":"Injectable nano-network for glucose-mediated insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2018.12.001_bb0435","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1021\/nn401617u","article-title":"Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2018.12.001_bb0440","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1021\/bm500364a","article-title":"Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin","volume":"15","author":"Tai","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2018.12.001_bb0445","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1021\/acs.chemmater.7b01804","article-title":"Glucose-responsive nanosystem mimicking the physiological insulin secretion via an enzyme\u2013polymer layer-by-layer coating strategy","volume":"29","author":"Xu","year":"2017","journal-title":"Chem. Mater."},{"key":"10.1016\/j.addr.2018.12.001_bb0450","doi-asserted-by":"crossref","first-page":"22788","DOI":"10.1039\/c2jm34082h","article-title":"An injectable and glucose-sensitive nanogel for controlled insulin release","volume":"22","author":"Wu","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.addr.2018.12.001_bb0455","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.actbio.2017.09.044","article-title":"An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery","volume":"64","author":"Zhao","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2018.12.001_bb0460","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1080\/10717544.2017.1381200","article-title":"Insulin-loaded PLGA microspheres for glucose-responsive release","volume":"24","author":"Wu","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2018.12.001_bb0465","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.biomaterials.2008.02.016","article-title":"Functionalized injectable hydrogels for controlled insulin delivery","volume":"29","author":"Huynh","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2018.12.001_bb0470","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/adhm.201300490","article-title":"Ultrasound-triggered regulation of blood glucose levels using injectable nano-network","volume":"3","author":"Di","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2018.12.001_bb0475","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s12274-017-1500-z","article-title":"Ultrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsules","volume":"10","author":"Di","year":"2017","journal-title":"Nano Res."},{"key":"10.1016\/j.addr.2018.12.001_bb0480","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/jbm.820211202","article-title":"Magnetically enhanced insulin release in diabetic rats","volume":"21","author":"Kost","year":"1987","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.addr.2018.12.001_bb0485","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2010.07.008","article-title":"Microcapsules of alginate\/chitosan containing magnetic nanoparticles for controlled release of insulin","volume":"81","author":"Finotelli","year":"2010","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.addr.2018.12.001_bb0490","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1073\/pnas.1322651111","article-title":"Near-infrared-actuated devices for remotely controlled drug delivery","volume":"111","author":"Timko","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2018.12.001_bb0495","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/btm2.10036","article-title":"Stimuli-responsive delivery of therapeutics for diabetes treatment","volume":"1","author":"Yu","year":"2016","journal-title":"Bioeng. Transl. Med."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1830303X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X1830303X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T04:45:53Z","timestamp":1759207553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X1830303X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":99,"alternative-id":["S0169409X1830303X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2018.12.001","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}